Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma

Clinical Lymphoma, Myeloma and Leukemia

Volumn 10, Issue 5, 2010, Pages

  Lipstein, Mark ^a   O'Connor, Owen ^b   Montanari, Francesca ^b   Paoluzzi, Luca ^c   Bongero, Danielle ^b   Bhagat, Govind ^d  

^a UNIVERSITY OF ROCHESTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c GREENWICH HOSPITAL   (United States)

^d Department of Medicine   (United States)

Author keywords

Diffuse large B cell lymphoma; Non Hodgkin lymphoma; R CHOP

Indexed keywords

ALLOPURINOL; BORTEZOMIB; CARBOPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; RITUXIMAB; STEROID; VINCRISTINE;

AGED; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY FAILURE; LARGE CELL LYMPHOMA; MALE; PLASMABLASTIC LYMPHOMA; SEPTICEMIA; TREATMENT RESPONSE; TUMOR LYSIS SYNDROME; URINARY TRACT INFECTION; UROSEPSIS;

EID: 79952996426     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2010.n.074     Document Type: Article

References (15)

1. Swerdlow SH, Harris NL, Jaffe ES, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. 4th edition ed: IARC; 2008.
2. Takahashi Y, Saiga I, Fukushima J, et al. Plasmablastic lymphoma of the retroperitoneum in an HIV-negative patient. Pathol Int 2009; 59:868-73.
3. Lin F, Zhang K, Quiery AT, Jr, et al. Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 2004; 128:581-4. (Pubitemid 38579601)
4. Masgala A, Christopoulos C, Giannakou N, et al. Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman. Ann Hematol 2007; 86:615-8. (Pubitemid 47018481)
5. Thakral C, Thomas L, Gajra A, et al. Plasmablastic lymphoma in an immunocompetent patient. J Clin Oncol 2009; 27:e78-81.
6. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005; 18:806-15. (Pubitemid 40780514)
7. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89:1413-20. (Pubitemid 27080006)
8. Lester R, Li C, Phillips P, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 2004; 45:1881-5. (Pubitemid 38997157)
9. Panos G, Karveli EA, Nikolatou O, et al. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol 2007; 82:761-5. (Pubitemid 47221664)
10. Riedel DJ, Gonzalez-Cuyar LF, Zhao XF, et al. Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection. Lancet Infect Dis 2008; 8:261-7. (Pubitemid 351382027)
11. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 2008; 83:804-9.
12. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogeneous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004; 15:1673-9. (Pubitemid 39562609)
13. Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis 2009; 15:38-45.
14. Gerecitano J, Portlock CS, Hamlin PA, et al. Rituximab, cyclophosphamide, bortezomib and prednisone (R-CBorP): final results of a phase I trial evaluating two dosing schedules and the safety of overlapping pegfilgrastim in patients with relapsed/refractory indolent and mantle cell lymphomas. Presented at: the 51st American Society of Hematology Annual Meeting and Exposition; December 5-8, 2006; New Orleans, LA. Abstract 3708.
15. Bose P, Thompson C, Gandhi D, et al. AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib. Eur J Haematol 2009; 82:490-2.